Leelyn Smith, LLC Abb Vie Inc. Transaction History

Leelyn Smith, LLC

$543 Million
Q3 2024

A detailed history of Leelyn Smith, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Leelyn Smith, LLC holds 18,590 shares of ABBV stock, worth $3.26 Million. This represents 0.68% of its overall portfolio holdings.

Number of Shares

18,590

Previous 18,619 0.16%

Holding current value

$3.26 Million

Previous $3.19 Million 14.97%

% of portfolio

0.68%

Previous 0.62%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$163.84 - $199.33 $4,751 - $5,780	-29 Reduced 0.16%	18,590 $3.67 Million
Q2 2024 Aug 08, 2024	SELL	$154.79 - $180.76 $92,409 - $107,913	-597 Reduced 3.11%	18,619 $3.19 Million
Q1 2024 May 13, 2024	SELL	$159.82 - $182.1 $73,037 - $83,219	-457 Reduced 2.32%	19,216 $3.5 Million
Q4 2023 Feb 08, 2024	SELL	$137.6 - $154.97 $75,404 - $84,923	-548 Reduced 2.71%	19,673 $3.05 Million
Q3 2023 Nov 06, 2023	SELL	$133.59 - $154.65 $64,390 - $74,541	-482 Reduced 2.33%	20,221 $3.01 Million
Q2 2023 Aug 10, 2023	SELL	$132.51 - $164.9 $118,993 - $148,080	-898 Reduced 4.16%	20,703 $2.79 Million
Q1 2023 May 12, 2023	SELL	$144.61 - $166.54 $10,267 - $11,824	-71 Reduced 0.33%	21,601 $3.44 Million
Q4 2022 Feb 10, 2023	BUY	$138.31 - $165.87 $116,595 - $139,828	843 Added 4.05%	21,672 $3.5 Million
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $58,918 - $67,575	-439 Reduced 2.06%	20,829 $2.8 Million
Q2 2022 Aug 09, 2022	SELL	$137.62 - $174.96 $75,966 - $96,577	-552 Reduced 2.53%	21,268 $3.26 Million
Q1 2022 May 11, 2022	SELL	$131.98 - $163.75 $923 - $1,146	-7 Reduced 0.03%	21,820 $3.54 Million
Q4 2021 Feb 14, 2022	SELL	$107.43 - $135.93 $75,953 - $96,102	-707 Reduced 3.14%	21,827 $2.96 Million
Q3 2021 Nov 12, 2021	BUY	$106.4 - $120.78 $15,002 - $17,029	141 Added 0.63%	22,534 $2.43 Million
Q2 2021 Aug 31, 2021	SELL	$105.21 - $117.21 $11,888 - $13,244	-113 Reduced 0.5%	22,393 $2.52 Million
Q1 2021 May 05, 2021	BUY	$102.3 - $112.62 $77,134 - $84,915	754 Added 3.47%	22,506 $2.44 Million
Q4 2020 Jan 15, 2021	BUY	$80.49 - $108.67 $32,276 - $43,576	401 Added 1.88%	21,752 $2.33 Million
Q3 2020 Nov 05, 2020	SELL	$85.91 - $100.83 $11,511 - $13,511	-134 Reduced 0.62%	21,351 $1.87 Million
Q2 2020 Aug 06, 2020	SELL	$73.37 - $98.18 $30,375 - $40,646	-414 Reduced 1.89%	21,485 $2.11 Million
Q1 2020 May 06, 2020	BUY	$64.5 - $97.79 $151,768 - $230,099	2,353 Added 12.04%	21,899 $1.6 Million
Q4 2019 Feb 06, 2020	BUY	$72.13 - $90.25 $1.41 Million - $1.76 Million	19,546 New	19,546 $1.73 Million

Others Institutions Holding ABBV

# of Institutions

3,855

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Leelyn Smith, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Leelyn Smith, LLC with notifications on news.

Account